Last reviewed · How we verify
NCT05828264
The Effect of "Quantum-Touch" on Pain, Fear, and Anxiety of the Children
NA trial testing Quantum touch in Pain, Acute in 113 participants. Completed in 1 April 2023.
1 April 2023
Quick facts
| Lead sponsor | Trakya University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 113 |
| Start date | 1 September 2022 |
| Primary completion | 1 April 2023 |
| Estimated completion | 1 April 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Quantum touch
Conditions studied
- Pain, Acute — all drugs for Pain, Acute →
- Child Behavior — all drugs for Child Behavior →
- Anxiety and Fear — all drugs for Anxiety and Fear →
- Venipuncture Site Reaction — all drugs for Venipuncture Site Reaction →
Sponsor
Trakya University
Who can join
Adults 7 to 12, any sex, with Pain, Acute or Child Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research is a randomized controlled experimental study designed to determine the effect of the Quantum-Touch method applied during the vascular access procedure in children aged 7-12 years, on the level of pain, fear and anxiety in children.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05828264
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain, Acute
Currently open trials in the same condition.
- NCT07249827 — A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guid · Phase 2 · recruiting
- NCT07053774 — Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain · Phase 2 · recruiting
- NCT07009951 — Impact of Virtual Reality in Cardiac Electrophysiology · recruiting
- NCT06960317 — Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements · NA · recruiting
- NCT06754657 — CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery · Phase 4 · recruiting
Other Trakya University trials
Trials by the same sponsor.
- NCT07443735 — Pinwheel and Bubble Blowing for Pain and Emotional Responses in Children · NA · not yet recruiting
- NCT07464795 — The Effects of Kinesio Taping on Heel-Rise Endurance and Gastrocnemius Muscle Oxygenation in Healthy Young Adults · NA · not yet recruiting
- NCT07421687 — 3D Volumetric Plaque Assessment on Teeth, Composite Restorations, and Ceramic Veneers Using an Intraoral Scanner · not yet recruiting
- NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
- NCT07349056 — Early Effects of Orthognathic Surgery on Periodontal Phenotype: A 6-Month Prospective Clinical and Radiographic Evaluati · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05828264 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Trakya University
- Last refreshed: 25 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05828264.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing